NCT04164979 2025-08-11Ph II Study of Cabozantinib With Pembrolizumab in Metastatic Gastric and Gastroesophageal AdenocarcinomaUniversity of California, IrvinePhase 2 Active not recruiting34 enrolled 11 charts
NCT06938139 2025-04-22Defining Benchmarks for Gastric Cancer Patients Underwent Minimal Invasive GastrectomyFujian Medical UniversityActive not recruiting90,000 enrolled